Search ResultsElectronic Resources 
by
Springer, Aaron David, author.
Format:
Excerpt:
Delivery of RNAi Therapeutics: Building Multifunctional RNAi Triggers for Extra-Hepatic Targeting
by
Sheets, Anthony Robert, author.
Format:
Excerpt:
Restoring Angiogenic Balance in Diabetes: Advanced Molecular Therapeutics for Non-Healing Diabetic
by
Fang, Pingping, author.
Format:
Excerpt:
University of Kansas. Pharmacology, Toxicology & Therapeutics. degree granting institution.
by
Shum, Laura C., author.
Format:
Excerpt:
bone quality. Elucidating the mechanisms for declining bone quality can lead to better therapeutics. A
by
Lundberg, Lindsay N., author.
Format:
Excerpt:
Category B Pathogen by NIAID. There are no FDA-approved therapeutics or vaccines for human use. Thus, it is
by
Dancy, Jimena Guadalupe, author.
Format:
Excerpt:
contribute to positive disease outcomes. However, while targeting therapeutics to specific disease components
by
Parcon, Paul A., author.
Format:
Excerpt:
risk factors for AD, and could lead to directed development of therapeutics to harness autophagy
by
O'Neill, Sharon M., author.
Format:
Excerpt:
. Research aimed at generation of novel potential therapeutics for MS is needed. Recently, kallikrein 6 (KLK6
by
Gill, Taylor Elizabeth, author.
Format:
Excerpt:
these molecules as specific modulators of MYC expression and as prototypical MYC-directed therapeutics.
by
Drufva, Erin, author. (orcid)0000-0001-6497-9949
Format:
Excerpt:
diverse applications including biosynthesis, biocatalysis, therapeutics, drug delivery, and bioremediation
by
Negrón Abril, Yashira L., author.
Format:
Excerpt:
, we tested SIRT5-selective small molecule inhibitors as cancer therapeutics. Pharmacological

Select an Action





